-
PROVIDERS
New MRD Medicare Coverage for Select Indications*
*When coverage criteria are met. Additional criteria and exceptions for coverage may apply.
-
LIFE SCIENCES
Register now
UPCOMING WEBINARTranslating data into an actionable R&D strategy
-
PATIENTS
It's About Time
View the Tempus vision.
- RESOURCES
-
ABOUT US
View Job Postings
We’re looking for people who can change the world.
- INVESTORS
01/27/2025
Addressing health disparities at a large academic medical center: AI-driven cardiac care for aortic stenosis and mitral regurgitation
Leveraging a natural language processing (NLP) based, artificial intelligence (AI) driven protocol, Tempus Next worked to help clinicians improve management of patients with severe aortic stenosis (sAS) and severe mitral regurgitation (sMR) by identifying patients who may have been previously overlooked.
-
02/12/2026Beyond the EHR: Building a reliable mortality endpoint for oncology research
Emilie Scherrer, Senior Director and Head of Outcomes Research, explains how Tempus’ validated, composite mortality endpoint overcomes data fragmentation to provide a trustworthy foundation for real-world evidence.
Read more -
02/05/2026Accelerating a phase 1 oncology trial: The TIME Network’s impact on patient enrollment
For life sciences companies, speed and precision are paramount. The ability to efficiently launch a Phase 1 trial and generate early clinical data is fundamental to long-term success. The Tempus TIME Trial Network provides the infrastructure to help achieve these goals.
Read more -
02/05/2026Building the engine to scale data abstraction through AI
Learn how Tempus’ AI engine, built on agentic architectures, transforms unstructured clinical text into analysis-ready real-world data. Tempus AI leaders detail the multi-layered system that ensures speed, scale, and fidelity.
Read more